Press Releases

Date	Title	Company
21-Mar-2023	'More Advanced Diagnostic Testing is Crucial for Preventing an Avian Flu Pandemic’	Pictura Bio
21-Mar-2023	SpyBiotech Receives Grant to Advance Novel SpyVector Platform That Improves Efficacy and Boosting Capability of Adenovirus-based Vaccines Against Current and Future Pandemic Viruses	SpyBiotech
21-Mar-2023	LYNPARZA (OLAPARIB) APPROVED IN THE UK AS COMBINATION THERAPY FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHEN CHEMOTHERAPY IS NOT CLINICALLY INDICATED	AstraZeneca
21-Mar-2023	2023 PM Society Awards – Winners Announced	PM Society
21-Mar-2023	MHRA to streamline clinical trial approvals in biggest overhaul of trial regulation in 20 years	MHRA
21-Mar-2023	Intrauterine Insemination Devices Market is expected to be valued at US$ 57.5 million by 2033 \| FMI Analyst	MARKITWIRED
21-Mar-2023	Altasciences Selects Proscia To Accelerate The Development Of Life-Saving Drugs	Proscia
21-Mar-2023	Sustainability takes centre stage for Tower Cold Chain at LogiPharma	Tower Cold Chain
21-Mar-2023	Virtual Reality Transforms EDI Training at Chelsea and Westminster Hospital NHS Foundation Trust	CW+
21-Mar-2023	LYNPARZA (OLAPARIB) APPROVED IN THE UK AS COMBINATION THERAPY FOR TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHEN CHEMOTHERAPY IS NOT CLINICALLY INDICATED	AstraZeneca and MSD
21-Mar-2023	Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery	BHV Partners
21-Mar-2023	Rancho Biosciences Welcomes Regeneron as the Newest Member to Its Single Cell Data Science Consortium	Newswire
21-Mar-2023	LighthouseAI Announces Innovative AI-Based Compliance Solution for the Life Sciences Industry	Newswire
21-Mar-2023	Exeliom Biosciences Announces First Patient Enrolled in Phase 1 Study for the Maintenance in Remission in Adult Patients With Mild to Moderate Crohn's Disease	Newswire
21-Mar-2023	Evotec SE to announce preliminary financial results for fiscal year 2022 on 28 March 2023	Evotec SE
21-Mar-2023	Eisenmenger Complex Management Market to reach US$ 12.9 billion in 2033	MARKITWIRED
21-Mar-2023	Head and Neck Cancer (HNC) Therapeutics market is forecast to reach US$ 5.19 Billion by 2033, growing at a CAGR of 12.6% until 2033	MARKITWIRED
21-Mar-2023	Filariasis Treatment Market to reach US$ 28.68 Billion by 2033, Drugs to account for Bulk of all Treatments \| FMI Study	MARKITWIRED
21-Mar-2023	New Innovations opens Prospects for the Cancer Vaccine Market, Propelling the Growth of Market at 12% CAGR through 2033	MARKITWIRED
21-Mar-2023	Hyperpigmentation Treatment Market is expected to be valued at US$ 4.78 Billion in 2023	MARKITWIRED